USPTO serial 98538441
Serial No. 98538441
Reviewed by CopyMark Law Group
Status 601
- Filing date
- Status date
- Registration date
- —
- Examiner
- —
- Law office
- —
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with Serial No. 98538441?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
David W. Staple
David W. Staple Casimir Jones, S.C.2275 Deming Way, Suite 310Middleton, WI 53562United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Pharmaceutical preparations, namely, IVIG (Intravenous Immunoglobulin); immune globulin and hyperimmune globulin for pharmaceutical purposes; immune globulin and hyperimmune globulin preparations for the treatment of primary and secondary immunodeficiencies; immune globulin and hyperimmune globulin preparations for the prevention or treatment of infectious diseases; hyperimmune globulin preparation for the prevention or treatment of hepatitis B | ACTIVE | Oct 10, 2019 |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| May 22, 2024 | MAB1 | ABANDONMENT NOTICE MAILED - EXPRESS ABANDONMENT | — |
| May 22, 2024 | ABN1 | ABANDONMENT - EXPRESS MAILED | — |
| May 21, 2024 | EXAR | TEAS EXPRESS ABANDONMENT RECEIVED | — |
| May 7, 2024 | NWAP | NEW APPLICATION ENTERED | — |